New weight loss pill approved for use in UK
The UK has become the first European country to approve 'Foundayo,' a daily weight-loss pill developed by Eli Lilly. While the drug is approved for private use, its availability on the NHS remains subject to further regulatory review.
Why it matters
The approval of oral GLP-1 medications offers a more convenient alternative to injectable weight-loss treatments, potentially increasing access to obesity care.
Image source, Getty Images By Nick Triggle Health correspondent Published 20 minutes ago A daily weight-loss pill made by the drug firm behind the Mounjaro jab has been approved for use in the UK - the first country in Europe to do so.
Foundayo, made by Eli Lilly, is for treating obesity and type 2 diabetes.
But while people will be able to buy it privately with a prescription, the approval by the Medicines and Healthcare productors Regulatory Agency does not automatically mean it will be made available on the NHS.
Foundayo is a form of GLP-1 medication that blunts appetite, and comes after the MHRA approved a pill version of a similar weight-loss drug, Wegovy, in June.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in